ELOX

Eloxx Pharmaceuticals, Inc. - Common Stock (ELOX)

About Eloxx Pharmaceuticals, Inc. - Common Stock (ELOX)

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.

Details

Daily high

$16.02

Daily low

$15.00

Price at open

$15.46

52 Week High

$23.40

52 Week Low

$0.00

Market cap

62.2M

Dividend yield

Volume

38,386

Avg. volume

23,658

P/E ratio

Eloxx Pharmaceuticals, Inc. - Common Stock News